PJO

Benziodarone

Created:	2023-03-06
Last modified:	2023-11-01

Find Related PDB Entry
1 entries where PJO is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	34
Chiral Atom Count	0
Bond Count	36
Aromatic Bond Count	16

2D diagram of PJO

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	Benziodarone
Synonyms	Amplivix; Dilafurane
Systematic Name (OpenEye OEToolkits)	[3,5-bis(iodanyl)-4-oxidanyl-phenyl]-(2-ethyl-1-benzofuran-3-yl)methanone
Formula	C₁₇ H₁₂ I₂ O₃
Molecular Weight	518.084
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	CCc1oc2ccccc2c1C(=O)c3cc(I)c(O)c(I)c3
SMILES	OpenEye OEToolkits	2.0.7	CCc1c(c2ccccc2o1)C(=O)c3cc(c(c(c3)I)O)I
Canonical SMILES	CACTVS	3.385	CCc1oc2ccccc2c1C(=O)c3cc(I)c(O)c(I)c3
Canonical SMILES	OpenEye OEToolkits	2.0.7	CCc1c(c2ccccc2o1)C(=O)c3cc(c(c(c3)I)O)I
InChI	InChI	1.06	InChI=1S/C17H12I2O3/c1-2-13-15(10-5-3-4-6-14(10)22-13)16(20)9-7-11(18)17(21)12(19)8-9/h3-8,21H,2H2,1H3
InChIKey	InChI	1.06	CZCHIEJNWPNBDE-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB13277
Name	Benziodarone
Groups	approved withdrawn
Description	Benziodarone is a uricostatic and a uricosuric agent which is sold also under the name Amplivex-Labaz. It is used in the treatment of gout [A175630]. It was withdrawn from France markets and British markets due to its effects causing Jaundice in patients [T487, A175636].
Synonyms	Benziodarone
Categories	Antigout Preparations Antirheumatic Agents Cardiac Therapy Heterocyclic Compounds, Fused-Ring Uricosuric Agents Vasodilators Used in Cardiac Diseases
ATC-Code	C01DX54 C01DX04
CAS number	68-90-6

Related Resource References

Resource Name	Reference
PubChem	6237
ChEMBL	CHEMBL232201
ChEBI	CHEBI:135814
CCDC/CSD	SATJOM

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.